How should a 67-year-old male vegetarian with chronic leukopenia, anemia, and neutropenia be evaluated and managed?

Evaluation and Management of Chronic Cytopenias in a 67-Year-Old Vegetarian Male

This patient requires immediate evaluation for myelodysplastic syndrome (MDS) with bone marrow examination and cytogenetics, while simultaneously correcting nutritional deficiencies—particularly iron and B12—which are common culprits of chronic cytopenias in vegetarians and may resolve the hematologic abnormalities.

Initial Diagnostic Approach

The combination of chronic leukopenia, anemia, and neutropenia demands exclusion of serious hematologic disorders before attributing findings to nutritional causes alone. The vegetarian diet is a critical clue pointing toward specific deficiencies.

Essential First-Line Testing

• Complete blood count with differential (repeat to confirm chronicity if >3 months) 1
• Peripheral blood smear to assess cell morphology
• Nutritional assessment: Iron studies (ferritin, transferrin saturation, TIBC), vitamin B12, and folate levels 2
• Autoimmune screening: ANA, anti-thyroid antibodies, rheumatoid factor (autoimmunity accounts for >50% of isolated leukopenia cases) 2
• Bone marrow examination with cytogenetics is mandatory to exclude MDS, particularly given the patient's age and multiple cytopenias 3, 1, 4

Critical Nutritional Considerations in Vegetarians

Iron deficiency is remarkably underrecognized as a cause of both anemia AND leukopenia/neutropenia. A compelling case report demonstrated complete resolution of 16-year chronic idiopathic neutropenia after correcting iron deficiency 5. In studies of isolated leukopenia, iron deficiency anemia was the leading cause in non-neutropenic patients (21.8%) and second most common in neutropenic patients (10.2%) 2.

Vegetarians are at particularly high risk for:

• Iron deficiency (non-heme iron has poor bioavailability)
• Vitamin B12 deficiency (absent in plant-based foods unless fortified)
• Both deficiencies can cause pancytopenia or isolated cytopenias

Management Algorithm

If Nutritional Deficiencies Are Identified:

1. Initiate oral iron supplementation (ferrous sulfate 325 mg daily or equivalent) if ferritin <100 ng/mL or transferrin saturation <20% 5, 2

   • Monitor CBC monthly for 2-3 months
   • Expect improvement in both anemia and leukopenia/neutropenia if iron-related

2. B12 replacement if levels <200 pg/mL (intramuscular 1000 mcg weekly for 4-8 weeks, then monthly maintenance)

3. Reassess after 2-3 months of supplementation before pursuing more aggressive interventions

If MDS Is Diagnosed:

For lower-risk MDS with chronic anemia:

• Maintain hemoglobin ≥8 g/dL (or 9-10 g/dL with comorbidities) through RBC transfusions 3
• Transfuse sufficient units to raise hemoglobin >10 g/dL to optimize quality of life 3
• Consider iron chelation after 20-60 RBC units or ferritin >1000-2500 μg/L to prevent cardiac complications 3

For neutropenia management:

• Prophylactic antibiotics and G-CSF are NOT recommended for chronic neutropenia in MDS 3
• Reserve G-CSF for active severe infections only (short-term use during febrile episodes) 3, 6
• Initiate broad-spectrum antibiotics immediately with fever or infection symptoms 3

If Chronic Idiopathic Neutropenia Is Diagnosed:

G-CSF therapy is indicated only if:

• ANC consistently <500/μL with recurrent infections 6, 4
• Dosing: Start 1-3 mcg/kg subcutaneously daily or 2-3 times weekly, titrated to maintain ANC in low-normal range 6
• Important caveat: Patients with cyclic, idiopathic, or autoimmune neutropenia have virtually no risk of MDS/AML progression 4

If Autoimmune Etiology Is Found:

Treat the underlying autoimmune condition (thyroid disease, rheumatologic disorder) as this may resolve the cytopenias 2.

Critical Pitfalls to Avoid

1. Do not dismiss nutritional causes in vegetarians—iron and B12 deficiency can fully explain this presentation and are reversible 5, 2

2. Do not start prophylactic G-CSF without clear indication—it does not improve survival in MDS and increases costs without benefit in stable chronic neutropenia 3, 6

3. Do not delay bone marrow examination—MDS risk increases with age, and early diagnosis affects prognosis and treatment decisions 3, 1

4. Do not overlook drug-induced causes—review all medications as drugs account for 8-13% of isolated leukopenia cases 2

5. Monitor for MDS/AML transformation in severe congenital neutropenia requiring high-dose G-CSF (>10 mcg/kg/day), though this risk is minimal in idiopathic/autoimmune neutropenia 6, 4

Monitoring Strategy

• Monthly CBC during initial nutritional repletion phase
• Every 3-6 months if stable chronic idiopathic neutropenia without infections
• Annual bone marrow examination only if concerning features develop (worsening cytopenias, new cytogenetic abnormalities, blast increase) 1, 4

The vegetarian diet strongly suggests this may be nutritionally mediated, making empiric supplementation with iron and B12 both diagnostic and therapeutic while awaiting definitive bone marrow results 5, 2.